Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
TBE Meningococcal Disease Influenza Smallpox
 
Disease

  Who should be vaccinated?

National recommendations vary and can change between Influenza seasons. Please refer to your national advisory committee on vaccination for country specific recommendations.

Generally, there are three main target groups that are said to be at a higher risk of developing a severe influenza infection:


The elderly
In Western Europe national recommendations vary from country to country. In most countries vaccination is recommended for persons over 65 years of age.

Persons with chronic illnesses
Persons with chronic illnesses including the following: pulmonary illnesses, such as emphysema, chronic bronchitis or asthma; cardiovascular illnesses, such as congestive heart failure; metabolic diseases including diabetes mellitus; renal dysfunction; hemoglobinopathies, such as sickle cell disease; immunosuppression.

Healthcare workers and residents of long term care facilities
In some countries it is also recommended to vaccinate healthcare workers and certain occupational groups (e.g. teachers, sales personnel) because of their potential of spreading the infection to those at high risk.

Others
The risk for exposure to influenza during travel depends on the time of year and destination. Individuals at high risk should consider influenza vaccination if they travel to the tropics, to the southern hemisphere during April September or when traveling as part of a large organized group that includes persons from areas where influenza is currently circulating.

Since national recommendations may vary, consult your physician with regard to groups which are routinely included in immunization programs in your country.


 » Printversion

 
 
  » find


 

Baxter initiates clinical study with cell-based candidate H5N1 Pandemic Vaccine
» read more

Baxter to participate in development of cell-based vaccines for U.S. Department of Health and Human Services
» read more

Baxter Receives Contract From National Health Service in United Kingdom to Produce Stockpile of H5N1 Flu Vaccine
» read more

 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,